SB225002 Secrets
Inhibition of EZH2 methyltransferase action may well signify a feasible method for the procedure of cancers with significant EZH2 action. The development of EZH2-specific inhibitors is an active place of investigation (nine, 11, 32). Indeed, GSK126 is among several candidate compounds which have been presently being evaluated in preclinical and sci